RXO (NYSE: RXO) reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.01 billion.

For earnings history and earnings-related data on RXO (RXO) click here.